GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » NeoPharm Co Ltd (XKRX:092730) » Definitions » Total Equity

NeoPharm Co (XKRX:092730) Total Equity : ₩160,253 Mil (As of Mar. 2024)


View and export this data going back to 2007. Start your Free Trial

What is NeoPharm Co Total Equity?

NeoPharm Co's total equity for the quarter that ended in Mar. 2024 was ₩160,253 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


NeoPharm Co Total Equity Historical Data

The historical data trend for NeoPharm Co's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeoPharm Co Total Equity Chart

NeoPharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 105,692.61 117,717.55 130,304.93 142,210.81 160,025.95

NeoPharm Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 143,412.37 149,115.06 154,009.75 160,025.95 160,252.65

NeoPharm Co Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

NeoPharm Co's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=177458.519-17432.565
=160,026

NeoPharm Co's Total Equity for the quarter that ended in Mar. 2024 is calculated as

Total Equity=Total Assets(Q: Mar. 2024 )-Total Liabilities(Q: Mar. 2024 )
=183351.582-23098.937
=160,253

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NeoPharm Co Total Equity Related Terms

Thank you for viewing the detailed overview of NeoPharm Co's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


NeoPharm Co (XKRX:092730) Business Description

Traded in Other Exchanges
N/A
Address
928 Tamnip-dong, Yuseong-gu, Daejon, KOR, 305-510
NeoPharm Co Ltd is a South Korean company operating in the household and personal products. The products of the company include skin care brand, skin barrier special dermo cosmetic brand, hospital functional products, and life moisturizing body professional brand.

NeoPharm Co (XKRX:092730) Headlines

No Headlines